EXTH-45. THE REPURPOSED CUSP9 REGIMEN EXERTS POTENT ANTI-NEOPLASTIC ACTIVITY AGAINST GLIOBLASTOMA CELLS IN VITRO

OBJECTIVE: Drug repurposing is a strategy to safely accelerate the clinical application of therapeutics that provide anti-cancer activity. CUSP9 represents such a therapeutic regime which includes nine repurposed drugs along with low-dose temozolomide. In this work, we examined the biological activi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Halatsch, Marc-Eric, Kast, Richard Eric, Dwucet, Annika, Siegelin, Markus, Heiland, Tim, Karpel-Massler, Georg
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217344/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.393
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars